Key TakeawaysEli Lilly shares soared Thursday after the Mounjaro and Zepbound maker posted better second-quarter earnings than expected on soaring sales for its weight-loss drugs Mounjaro and Zepbound.The company also lifted its full-year revenue and profit guidance as its supply of weight-loss drugs improves.Eli Lilly shares jumped 12% before the opening bell and are up nearly 50% this year. Eli Lilly (LLY) shares surged higher in premarket trading Thursday after the drugmaker's second-quarter earnings cam ...